Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.

Caravita S, Faini A, Carolino D'Araujo S, Dewachter C, Chomette L, Bondue A, Naeije R, Parati G, Vachiéry JL.

PLoS One. 2018 Jun 19;13(6):e0199164. doi: 10.1371/journal.pone.0199164. eCollection 2018.

2.

Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis.

Caravita S, Dewachter C, Soranna D, D'Araujo SC, Khaldi A, Zambon A, Parati G, Bondue A, Vachiéry JL.

Eur Respir J. 2018 Apr 4;51(4). pii: 1702427. doi: 10.1183/13993003.02427-2017. Print 2018 Apr. No abstract available.

PMID:
29439019
3.

Mechanical versus humoral determinants of brain death-induced lung injury.

Belhaj A, Dewachter L, Rorive S, Remmelink M, Weynand B, Melot C, Hupkens E, Dewachter C, Creteur J, Mc Entee K, Naeije R, Rondelet B.

PLoS One. 2017 Jul 28;12(7):e0181899. doi: 10.1371/journal.pone.0181899. eCollection 2017.

4.

Roles of inflammation and apoptosis in experimental brain death-induced right ventricular failure.

Belhaj A, Dewachter L, Rorive S, Remmelink M, Weynand B, Melot C, Galanti L, Hupkens E, Sprockeels T, Dewachter C, Creteur J, McEntee K, Naeije R, Rondelet B.

J Heart Lung Transplant. 2016 Dec;35(12):1505-1518. doi: 10.1016/j.healun.2016.05.014. Epub 2016 May 24.

PMID:
27377219
5.

Bosentan reverses the hypoxia-induced downregulation of the bone morphogenetic protein signaling in pulmonary artery smooth muscle cells.

Maruyama H, Dewachter C, Sakai S, Belhaj A, Rondelet B, Remmelink M, Vachiéry JL, Naeije R, Dewachter L.

Life Sci. 2016 Aug 15;159:111-115. doi: 10.1016/j.lfs.2016.05.018. Epub 2016 May 14.

PMID:
27188586
6.

Myocardial Structural and Biological Anomalies Induced by High Fat Diet in Psammomys obesus Gerbils.

Sahraoui A, Dewachter C, de Medina G, Naeije R, Aouichat Bouguerra S, Dewachter L.

PLoS One. 2016 Feb 3;11(2):e0148117. doi: 10.1371/journal.pone.0148117. eCollection 2016.

7.

Myocardial inflammation in experimental acute right ventricular failure: Effects of prostacyclin therapy.

Dewachter C, Belhaj A, Rondelet B, Vercruyssen M, Schraufnagel DP, Remmelink M, Brimioulle S, Kerbaul F, Naeije R, Dewachter L.

J Heart Lung Transplant. 2015 Oct;34(10):1334-45. doi: 10.1016/j.healun.2015.05.004. Epub 2015 May 16.

PMID:
26087665
8.

Prevention of pulmonary hypoplasia and pulmonary vascular remodeling by antenatal simvastatin treatment in nitrofen-induced congenital diaphragmatic hernia.

Makanga M, Maruyama H, Dewachter C, Da Costa AM, Hupkens E, de Medina G, Naeije R, Dewachter L.

Am J Physiol Lung Cell Mol Physiol. 2015 Apr 1;308(7):L672-82. doi: 10.1152/ajplung.00345.2014. Epub 2015 Jan 23.

9.

Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.

Maruyama H, Dewachter C, Belhaj A, Rondelet B, Sakai S, Remmelink M, Vachiery JL, Naeije R, Dewachter L.

J Heart Lung Transplant. 2015 Mar;34(3):468-78. doi: 10.1016/j.healun.2014.09.011. Epub 2014 Sep 28.

PMID:
25447587
10.

Heme oxygenase-1 and inflammation in experimental right ventricular failure on prolonged overcirculation-induced pulmonary hypertension.

Belhaj A, Dewachter L, Kerbaul F, Brimioulle S, Dewachter C, Naeije R, Rondelet B.

PLoS One. 2013 Jul 25;8(7):e69470. doi: 10.1371/journal.pone.0069470. Print 2013.

11.

Downregulated bone morphogenetic protein signaling in nitrofen-induced congenital diaphragmatic hernia.

Makanga M, Dewachter C, Maruyama H, Vuckovic A, Rondelet B, Naeije R, Dewachter L.

Pediatr Surg Int. 2013 Aug;29(8):823-34. doi: 10.1007/s00383-013-3340-6. Epub 2013 Jul 6.

PMID:
23832098
12.

Prolonged overcirculation-induced pulmonary arterial hypertension as a cause of right ventricular failure.

Rondelet B, Dewachter C, Kerbaul F, Kang X, Fesler P, Brimioulle S, Naeije R, Dewachter L.

Eur Heart J. 2012 Apr;33(8):1017-26. doi: 10.1093/eurheartj/ehr111. Epub 2011 May 23.

PMID:
21606077
13.

Sildenafil added to sitaxsentan in overcirculation-induced pulmonary arterial hypertension.

Rondelet B, Dewachter L, Kerbaul F, Dewachter C, Hubloue I, Fesler P, Franck S, Remmelink M, Brimioulle S, Naeije R.

Am J Physiol Heart Circ Physiol. 2010 Oct;299(4):H1118-23. doi: 10.1152/ajpheart.00418.2010. Epub 2010 Aug 6.

14.

Early right ventriculo-arterial uncoupling in borderline pulmonary hypertension on experimental heart failure.

Pagnamenta A, Dewachter C, McEntee K, Fesler P, Brimioulle S, Naeije R.

J Appl Physiol (1985). 2010 Oct;109(4):1080-5. doi: 10.1152/japplphysiol.00467.2010. Epub 2010 Aug 5.

15.

Activation of apoptotic pathways in experimental acute afterload-induced right ventricular failure.

Dewachter C, Dewachter L, Rondelet B, Fesler P, Brimioulle S, Kerbaul F, Naeije R.

Crit Care Med. 2010 Jun;38(6):1405-13. doi: 10.1097/CCM.0b013e3181de8bd3.

PMID:
20431484
16.

New therapies for pulmonary arterial hypertension: an update on current bench to bedside translation.

Dewachter L, Dewachter C, Naeije R.

Expert Opin Investig Drugs. 2010 Apr;19(4):469-88. doi: 10.1517/13543781003727099. Review.

PMID:
20367190
17.

How prostacyclin improves cardiac output in right heart failure in conjunction with pulmonary hypertension.

Kerbaul F, Brimioulle S, Rondelet B, Dewachter C, Hubloue I, Naeije R.

Am J Respir Crit Care Med. 2007 Apr 15;175(8):846-50. Epub 2007 Feb 1.

PMID:
17272784

Supplemental Content

Loading ...
Support Center